A comparative study of human chorionic gonadotropin, placebo, and bed rest for women with early threatened abortion
- PMID: 8348164
A comparative study of human chorionic gonadotropin, placebo, and bed rest for women with early threatened abortion
Abstract
Objective: To compare the effect of hCG therapy with placebo or bed rest in women with threatened abortion.
Design: Random assignment, double-blind.
Setting: Community hospitals.
Patients and interventions: Sixty-one women with viable pregnancies under 8 weeks' gestation on admission to hospital were randomly allocated to receive injections of hCG or placebo, or were advised to rest in bed.
Main outcome measures: Abortion vs. continuation of pregnancy at 16 weeks' gestation.
Results: Thirty-one aborted: 6/20 on hCG, 10/21 on placebo, 15/20 on bed rest. hCG vs. bed rest, P < .01; placebo vs. bed rest, hCG vs. placebo--not significant. Plasma progesterone: continuing pregnancy > abortion, P < .01; continued with hCG vs. aborted on placebo, P < .001; continued with hCG vs. aborted with bed rest, P < .001. No significant differences in pregnancy/birth complications or infants' birth weight. Female/male ratio was 2:1.
Conclusions: hCG is significantly better than bed rest.
Similar articles
-
First trimester threatened miscarriage treatment with human chorionic gonadotrophins: a randomised controlled trial.BJOG. 2005 Nov;112(11):1536-41. doi: 10.1111/j.1471-0528.2005.00750.x. BJOG. 2005. PMID: 16225575 Clinical Trial.
-
Double-blind controlled trial of progesterone substitution in threatened abortion.Biol Res Pregnancy Perinatol. 1987;8(1 1ST Half):26-34. Biol Res Pregnancy Perinatol. 1987. PMID: 2437967 Clinical Trial.
-
Human chorionic gonadotropin, estradiol, progesterone, prolactin, and B-scan ultrasound monitoring of complications in early pregnancy.Obstet Gynecol. 1981 Feb;57(2):207-14. Obstet Gynecol. 1981. PMID: 7465126
-
Management of threatened abortion.Early Pregnancy. 1996 Dec;2(4):233-40. Early Pregnancy. 1996. PMID: 9363221 Review.
-
[Treatment of threatened pregnancy loss].Ugeskr Laeger. 2025 Jan 6;187(2):V07240474. doi: 10.61409/V07240474. Ugeskr Laeger. 2025. PMID: 39917893 Review. Danish.
Cited by
-
A randomized double-blind controlled trial of the use of dydrogesterone in women with threatened miscarriage in the first trimester: study protocol for a randomized controlled trial.Trials. 2016 Aug 17;17(1):408. doi: 10.1186/s13063-016-1509-8. Trials. 2016. PMID: 27534747 Free PMC article. Clinical Trial.
-
Bed rest during pregnancy for preventing miscarriage.Cochrane Database Syst Rev. 2005 Apr 18;2005(2):CD003576. doi: 10.1002/14651858.CD003576.pub2. Cochrane Database Syst Rev. 2005. PMID: 15846669 Free PMC article.
-
Rest during pregnancy for preventing pre-eclampsia and its complications in women with normal blood pressure.Cochrane Database Syst Rev. 2006 Apr 19;2006(2):CD005939. doi: 10.1002/14651858.CD005939. Cochrane Database Syst Rev. 2006. PMID: 16625644 Free PMC article.
-
PERİDER-TJOD joint review on threatened abortion and guideline for its treatment.Turk J Obstet Gynecol. 2025 Mar 10;22(1):96-105. doi: 10.4274/tjod.galenos.2025.36926. Turk J Obstet Gynecol. 2025. PMID: 40062715 Free PMC article.
-
Threatened miscarriage: evaluation and management.BMJ. 2004 Jul 17;329(7458):152-5. doi: 10.1136/bmj.329.7458.152. BMJ. 2004. PMID: 15258071 Free PMC article. Review. No abstract available.